The next wave of advanced therapies is already taking shape.

Our CEO Alexander Seyf joined The Medicine Maker‘s IBTV Roving Reporter at Advanced Therapies London 2026 to share his perspective on what emerging approaches could define the future of cell and gene therapy and why the industry’s toolkit is expanding well beyond traditional ex vivo methods.

🎥 From gene editing to iPSC-derived therapies, watch Alexander and other leading voices share their vision for making advanced therapies accessible to more patients. View the full video here.